Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines for various therapeutic areas, such as cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
Frequently asked questions
What sector does Dawnrays Pharmaceutical Holdings Ltd (2348) operate in?
Dawnrays Pharmaceutical Holdings Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Dawnrays Pharmaceutical Holdings Ltd (2348) current stock price?
As of the latest data, Dawnrays Pharmaceutical Holdings Ltd stock price is HK$0.98, with a previous close of HK$0.97. Dawnrays Pharmaceutical Holdings Ltd gained HK$0.01 in the last trading session, representing a 0.52% increase.
What is Dawnrays Pharmaceutical Holdings Ltd (2348) current market capitalization?
Dawnrays Pharmaceutical Holdings Ltd market cap is approximately 1.47 billion.
What is Dawnrays Pharmaceutical Holdings Ltd (2348) EBITDA?
Dawnrays Pharmaceutical Holdings Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 163.09 million.
Does Dawnrays Pharmaceutical Holdings Ltd (2348) pay dividends?
Yes. Dawnrays Pharmaceutical Holdings Ltd pays semiannual dividends with an annualized yield of 3.08% and an estimated annual payout of HK$0.03 per share.
When is the next ex-dividend date for Dawnrays Pharmaceutical Holdings Ltd (2348)?
The next ex-dividend date is scheduled for September 22, 2026.
What is Dawnrays Pharmaceutical Holdings Ltd (2348) beta (volatility) score?
Dawnrays Pharmaceutical Holdings Ltd has a beta of 0.227, indicating lower volatility than the overall market.
